Intuitive Surgical, Inc.

Intuitive Surgical, Inc.

IUI1 · XETRA · Healthcare / Medical Instruments & Supplies

403.90EUR+4.75 (+1.19%)

Price History

Full chart

Market Stats

Previous Close399.15
Open398.55
Day Range398.50 – 404.50
52-Week Range290.45 – 516.10
Volume946
Market Cap126.78B
P/E (TTM)45.89
Forward P/E33.33
EPS7.71
Dividend Yield0.00%
Beta1.47
50-Day Avg330.44
200-Day Avg381.70

About

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. David J. Rosa
  • Employees17.02K
  • Headquarters1020 Kifer Road, Sunnyvale, CA, United States, 94086-5304, Germany
  • Websitehttps://www.intuitive.com

Leadership

  • Dr. Gary S. Guthart Ph.D.Executive Chair · b. 1966
  • Mr. David J. RosaCEO & Director · b. 1968
  • Mr. Jamie E. SamathExecutive VP, CFO & Enterprise Technology Leader · b. 1971
  • Mr. Henry L. CharltonSenior VP of Global Business Operations · b. 1970
  • Mr. Gary H. Loeb J.D.Executive VP and Chief Legal & Compliance Officer · b. 1970
  • Mr. Mark P. BrosiusChief Manufacturing and Supply Chain Officer · b. 1967
  • Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller
  • Mr. Milind WagleChief Information Officer
  • Mr. Daniel P. Connally C.F.A.VP & Head of Investor Relations
  • Dr. Christopher R. Carlson Ph.D.Executive Vice President of Research, Corporate Development, Corporate Strategy & Intuitive Ventures

Financials

Income Statement

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue5.71B6.22B7.12B8.35B10.06B
Growth (%)-+8.97%+14.49%+17.24%+20.51%
Cost of Revenue1.75B2.03B2.39B2.72B3.42B
Gross Profit3.96B4.20B4.73B5.63B6.64B
Gross Margin69.32%67.44%66.39%67.46%66.00%
Operating Expense2.14B2.62B2.96B3.29B3.70B
Operating Income1.82B1.58B1.77B2.35B2.95B
Operating Margin31.89%25.35%24.80%28.12%29.27%
EBITDA-1.94B2.22B2.85B3.62B
EBITDA Margin-31.23%31.18%34.11%35.99%
Net Income1.70B1.32B1.80B2.32B2.86B
Net Income Margin29.85%21.25%25.24%27.81%28.38%
R&D671.00M879.00M998.80M1.15B1.31B
R&D as % of Total Revenue11.75%14.13%14.02%13.71%13.03%

Balance Sheet

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets13.55B12.97B15.44B18.74B20.46B
Total Liabilities1.60B1.86B2.04B2.21B2.52B
Total Equity11.90B11.04B13.31B16.43B17.82B
Cash1.29B1.58B2.75B2.03B3.37B

Cash Flow

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow2.09B1.49B1.81B2.42B3.03B
Financing Cash Flow43.00M-2.57B-287.60M150.90M-2.36B
Capital Expenditure339.50M532.40M1.06B1.11B539.80M
Free Cash Flow1.75B958.40M749.60M1.30B2.49B
FCF to OCF83.75%64.29%41.33%53.99%82.19%

Earnings

Report DateMar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jul 16, 2026Oct 20, 2026
EPS Estimate---------------------2.502.64
EPS Actual0.971.180.880.910.890.790.890.890.931.081.071.571.391.361.421.771.821.601.671.891.951.97-
Surprise----------------------21.23%-
Timing---------------------After-hoursAfter-hours

Key Statistics & Ratios

Market Cap126.78B
Enterprise Value119.36B
Trailing P/E45.89
Forward P/E33.33
PEG Ratio1.87
Price / Sales11.49
Price / Book7.83
EPS7.71
Book Value45.32
Revenue (TTM)11.03B
Gross Profit (TTM)7.36B
EBITDA4.18B
Profit Margin28.45%
Operating Margin33.60%
Return on Equity17.42%
Return on Assets10.51%
Shares Outstanding358.28M
Shares Float351.21M
Beta1.47
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Oct 5, 20213:1